Protalix BioTherapeutics, Inc. (DE) earnings per share and revenue

PLX earnings per share for the last quarter are -0.03 USD whereas the estimation was 0.02 USD which accounts for -250.00% surprise. Company revenue for the same period amounts to 13.47 M USD despite the estimated figure of 12.50 M USD. Estimated earnings per share for the next quarter are 0.06 USD, and revenue is expected to reach 16.26 M USD. Also watch annual changes over time to get a bigger picture of PLX earnings per share and revenue dynamics.